These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 36910075)

  • 81. Prevalence of asymptomatic valvular heart disease in the elderly population: a community-based echocardiographic study.
    Tsampasian V; Militaru C; Parasuraman SK; Loudon BL; Lowery C; Rudd A; Srinivasan J; Singh S; Dwivedi G; Mahadavan G; Dawson D; Clark A; Vassiliou VS; Frenneaux MP
    Eur Heart J Cardiovasc Imaging; 2024 Jul; 25(8):1051-1058. PubMed ID: 38925103
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Mitral regurgitation reduces systemic coagulation activity in patients with rheumatic heart disease.
    Cevik C; Otahbachi M; Nugent K; Ozkan M
    J Heart Valve Dis; 2009 May; 18(3):278-83. PubMed ID: 19557983
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Valvular and Nonvalvular Atrial Fibrillation in Patients Undergoing Transcatheter Aortic Valve Replacement.
    Okuno T; Hagemeyer D; Brugger N; Ryffel C; Heg D; Lanz J; Praz F; Stortecky S; Räber L; Roten L; Reichlin T; Windecker S; Pilgrim T
    JACC Cardiovasc Interv; 2020 Sep; 13(18):2124-2133. PubMed ID: 32972574
    [TBL] [Abstract][Full Text] [Related]  

  • 84. L1 cell adhesion molecule may be a protective molecule for atrial fibrillation in patients with valvular heart disease.
    Wang D; Hu B; Xu G; Wei R; Liu Z; Wu H; Xu L; Huang S; Hou J
    Heliyon; 2023 Jun; 9(6):e16831. PubMed ID: 37303506
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Clinical characteristics and 12-month outcomes of patients with valvular and non-valvular atrial fibrillation in Kenya.
    Temu TM; Lane KA; Shen C; Ng'ang'a L; Akwanalo CO; Chen PS; Emonyi W; Heckbert SR; Koech MM; Manji I; Vatta M; Velazquez EJ; Wessel J; Kimaiyo S; Inui TS; Bloomfield GS
    PLoS One; 2017; 12(9):e0185204. PubMed ID: 28934312
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Increased Risk of Valvular Heart Disease in Systemic Sclerosis: An Underrecognized Cardiac Complication.
    Kurmann RD; El-Am EA; Radwan YA; Sandhu AS; Crowson CS; Matteson EL; Warrington KJ; Mankad R; Makol A
    J Rheumatol; 2021 Jul; 48(7):1047-1052. PubMed ID: 33452164
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Identification of key immune-related genes and immune infiltration in atrial fibrillation with valvular heart disease based on bioinformatics analysis.
    Li S; Jiang Z; Chao X; Jiang C; Zhong G
    J Thorac Dis; 2021 Mar; 13(3):1785-1798. PubMed ID: 33841968
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Mechanism of atrial functional mitral regurgitation in patients with atrial fibrillation: A study using three-dimensional transesophageal echocardiography.
    Ito K; Abe Y; Takahashi Y; Shimada Y; Fukumoto H; Matsumura Y; Naruko T; Shibata T; Yoshiyama M; Yoshikawa J
    J Cardiol; 2017 Dec; 70(6):584-590. PubMed ID: 28527865
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Associations between waist circumference, central obesity, and the presence of non-valvular atrial fibrillation patients with heart failure.
    Wang B; Yang X; Wei B; Ren T; Huang N; Escobar C; Pang PYK; Liu X; Zhou H
    J Thorac Dis; 2024 Mar; 16(3):2049-2059. PubMed ID: 38617752
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Sinus Rhythm Conduction Properties across Bachmann's Bundle: Impact of Underlying Heart Disease and Atrial Fibrillation.
    Teuwen CP; Does LJMEV; Kik C; Mouws EMJP; Lanters EAH; Knops P; Taverne YJHJ; Bogers AJJC; de Groot NMS
    J Clin Med; 2020 Jun; 9(6):. PubMed ID: 32560096
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Plasma beta-thromboglobulin and platelet factor 4 concentrations in patients with atrial fibrillation.
    Yamauchi K; Furui H; Taniguchi N; Sotobata I
    Jpn Heart J; 1986 Jul; 27(4):481-7. PubMed ID: 2946878
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Influence of age on left atrial appendage function in patients with nonvalvular atrial fibrillation.
    Ilercil A; Kondapaneni J; Hla A; Shirani J
    Clin Cardiol; 2001 Jan; 24(1):39-44. PubMed ID: 11195605
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Long-term Thromboembolic Risk in Patients With Postoperative Atrial Fibrillation After Left-Sided Heart Valve Surgery.
    Butt JH; Olesen JB; Gundlund A; Kümler T; Olsen PS; Havers-Borgersen E; Aagaard DT; Gislason GH; Torp-Pedersen C; Køber L; Fosbøl EL
    JAMA Cardiol; 2019 Nov; 4(11):1139-1147. PubMed ID: 31596426
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Valvular heart disease: the influence of changing etiology on nosology.
    Boudoulas H; Vavuranakis M; Wooley CF
    J Heart Valve Dis; 1994 Sep; 3(5):516-26. PubMed ID: 8000586
    [TBL] [Abstract][Full Text] [Related]  

  • 95. In vivo model of drug-induced valvular heart disease in rats: pergolide-induced valvular heart disease demonstrated with echocardiography and correlation with pathology.
    Droogmans S; Franken PR; Garbar C; Weytjens C; Cosyns B; Lahoutte T; Caveliers V; Pipeleers-Marichal M; Bossuyt A; Schoors D; Van Camp G
    Eur Heart J; 2007 Sep; 28(17):2156-62. PubMed ID: 17636306
    [TBL] [Abstract][Full Text] [Related]  

  • 96. The Turkish registry of heart valve disease.
    Demirbağ R; Sade LE; Aydın M; Bozkurt A; Acartürk E
    Turk Kardiyol Dern Ars; 2013 Jan; 41(1):1-10. PubMed ID: 23518931
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Pattern of atrial fibrillation and risk of outcomes: the Loire Valley Atrial Fibrillation Project.
    Banerjee A; Taillandier S; Olesen JB; Lane DA; Lallemand B; Lip GY; Fauchier L
    Int J Cardiol; 2013 Sep; 167(6):2682-7. PubMed ID: 22795403
    [TBL] [Abstract][Full Text] [Related]  

  • 98. The association between systemic lupus erythematosus and valvular heart disease: an extensive data analysis.
    Watad A; Tiosano S; Grysman N; Comaneshter D; Cohen AD; Shoenfeld Y; Amital H
    Eur J Clin Invest; 2017 May; 47(5):366-371. PubMed ID: 28295225
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Pulmonary Hypertension with Valvular Heart Disease: When to Treat the Valve Disease and When to Treat the Pulmonary Hypertension.
    Martinez C; Tsugu T; Sugimoto T; Lancellotti P
    Curr Cardiol Rep; 2019 Nov; 21(12):151. PubMed ID: 31768665
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Left atrial appendage orifice area and morphology is closely associated with flow velocity in patients with nonvalvular atrial fibrillation.
    Chen L; Xu C; Chen W; Zhang C
    BMC Cardiovasc Disord; 2021 Sep; 21(1):442. PubMed ID: 34530731
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.